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Abstract
While much attention has been given to the problem of estimating the effect of discrete interventions from
observational data, relatively little work has been done in the setting of continuous-valued interventions,
such as treatments associated with a dosage parameter. In this paper, we tackle this problem by building
on a modification of the generative adversarial networks (GANs) framework. Our model, SCIGAN, is
flexible and capable of simultaneously estimating counterfactual outcomes for several different continuous
interventions. The key idea is to use a significantly modified GAN model to learn to generate counterfactual
outcomes, which can then be used to learn an inference model, using standard supervised methods, capable
of estimating these counterfactuals for a new sample. To address the challenges presented by shifting to
continuous interventions, we propose a novel architecture for our discriminator - we build a hierarchical
discriminator that leverages the structure of the continuous intervention setting. Moreover, we provide
theoretical results to support our use of the GAN framework and of the hierarchical discriminator. In
the experiments section, we introduce a new semi-synthetic data simulation for use in the continuous
intervention setting and demonstrate improvements over the existing benchmark models.
Keywords: continuous interventions, causal inference, treatment effects, generative adversarial networks
1. Introduction
Estimating the personalised effects of interventions is crucial for decision making in many domains such
as medicine, education, public policy and advertising. Such domains have a wealth of observational
data available. Most of the methods developed in the causal inference literature focus on learning the
counterfactual outcomes of discrete interventions, such as binary or categorical treatments1 (Bertsimas et al.,
2017; Alaa et al., 2017; Alaa and van der Schaar, 2017; Athey and Imbens, 2016; Wager and Athey, 2018;
Yoon et al., 2018). Unfortunately, in many cases, deciding how to intervene involves not only deciding
which intervention to make (e.g. whether to treat cancer with radiotherapy, chemotherapy or surgery) but
also deciding on the value of some continuous parameter associated with intervening (e.g. the dosage of
∗Equal contribution.
1For ease of exposition, we will sometimes refer to interventions as treatments and to the associated continuous parameter as
the dosage throughout the paper.
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Figure 1: Overview of GAN framework used in SCIGAN for learning the distribution of the counterfactual outcomes.
radiotherapy to be administered). In medicine there are many examples of treatments that are associated
with a continuous dosage parameter (such as vasopressors (Döpp-Zemel and Groeneveld, 2013)). In the
medical setting, using a high dosage for a treatment can lead to toxic effects while using a low dosage can
result in no effect on the patient outcome (Wang et al., 2017). In other domains, there are many examples of
continuous interventions, such as the duration of an education or job training program, the frequency of
an exposure or the price used in an advert. Naturally, being able to estimate the effect of these continuous
interventions will aid in the decision making process.
Learning from observational data already presents significant challenges when there is only a single
intervention (and thus the decision is binary - whether to intervene or not). As explained in Spirtes (2009),
in an observational dataset, only the factual outcome is present - the “counterfactual" outcomes are not
observed. This problem is exacerbated in the setting of continuous interventions where the number of
counterfactuals is no longer even finite. Moreover, the decision to intervene is non-random and instead
is assigned according to the features associated with each sample. Due to the continuous nature of the
interventions, adjusting for selection bias is significantly more complex than for binary (or even multiple)
interventions. Thus, standard methods for adjusting for selection bias for discrete treatments cannot be
easily extended to handle bias in the continuous setting.
In this paper we propose SCIGAN (eStimating the effects of Continuous Interventions using GANs).
We build on the GAN framework of Goodfellow et al. (2014) in order to learn the distribution of the
unobserved counterfactuals. GANs have already been used in GANITE (Yoon et al., 2018) to generate
the unobserved counterfactual outcomes for discrete interventions. The intuition is that if a counterfactual
generator and discriminator are trained adversarially, then the generator can fool the discriminator (i.e.
the discriminator will not be able to correctly identify the factual outcome) by generating counterfactuals
according to their true distribution. Unfortunately, no theoretical work was provided in Yoon et al. (2018)
to back up this intuition. A key contribution of this paper is to provide theoretical results that justify using
the GAN framework to learn to generate counterfactual outcomes; these results also apply to GANITE.
GANITE itself presents a significant modification to the original GAN framework - rather than the
discriminator discriminating between entirely real or entirely fake samples, the discriminator is attempting
to identify the real component from a vector containing the real (factual) outcome from the dataset and
the fake (counterfactual) outcomes generated by the generator. SCIGAN inherits this key difference
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from a standard GAN. However, beyond our theoretical contribution, we propose significant changes to
the generator and discriminator in order to tackle the more complex problem of estimating outcomes of
continuous interventions.
Naive attempts to extend Yoon et al. (2018) to the continuous setting might involve: (1) discretising the
continuous space of interventions; (2) somehow passing entire response curves to the discriminator and
asking it to identify the point on the curve that corresponds to the factual outcome.
Naturally, discretisation comes with a cost. If the discretisation is too coarse, the response curves
will not be well-approximated. On the other hand, we show experimentally that GANITE is incapable of
handling a high number of discrete interventions (corresponding to having a finer discretisation). In fact,
although SCIGAN was designed for continuous interventions, it can be applied in the discrete setting and
we show that it outperforms GANITE when the (discrete) parameter space is not small.
For (2), the problem is in defining a mechanism for generating these response curves in a form that
can be passed to the discriminator and ensuring the continuity of these curves around the factual outcome
so that the discontinuity itself does not make identification trivial for the discriminator. To overcome this
we define a discriminator that acts on a finite set of points from each generated response curve estimated
(rather than on entire curves), as shown in Fig. 1. From among the chosen points, the discriminator attempts
to identify the factual one. The set of points is sampled randomly each time an input would be passed to
the discriminator. As our discriminator will be acting on a set of random intervention-outcome pairs, we
explicitly condition it to behave as a function on a set. In particular, we draw on ideas from Zaheer et al.
(2017) to ensure that its output does not depend on the order of its input.
In addition, for the setting in which there are multiple possible interventions that each have an associated
continuous parameter (which is the main setting of the paper), we propose a hierarchical discriminator
which breaks down the job of the discriminator into determining the factual intervention and determining
the factual parameter using separate networks. We show in the experiments section that this approach
significantly improves performance and is more stable than using a single network discriminator. In this
setting, we also model the generator as a multi-task deep network capable of taking a continuous parameter
as an input; this gives us the flexibility to learn heterogeneous response curves for the different interventions.
Our contributions in this paper are 4-fold: (1) we propose SCIGAN, a significantly modified GAN
framework, capable of estimating outcomes for continuous and many-level-discrete interventions, (2) we
provide theoretical justification for both the use of a GAN framework and a hierarchical discriminator,
(3) we propose novel architectures for each of our networks, (4) we propose a new semi-synthetic data
simulation for use in the continuous intervention setting. We show, using semi-synthetic experiments, that
our model outperforms existing benchmarks.
2. Problem formulation
We consider receiving observations of the form (xi, tif , y
i
f ) for i = 1, ..., N , where, for each i, these are
independent realizations of the random variables (X, Tf , Yf ). We refer to X as the feature vector lying in
some feature space X , containing pre-treatment covariates (such as age, weight and lab test results). The
treatment random variable, Tf , is in fact a pair of values Tf = (Wf , Df ) whereWf ∈ W corresponds to the
type of treatment being administered (e.g. chemotherapy or radiotherapy) which lies in the discrete space of
k treatments,W = {w1, ..., wk}, and Df corresponds to the dosage of the treatment (e.g. number of cycles,
amount of chemotherapy, intensity of radiotherapy), which, for a given treatment w lies in the corresponding
treatment’s dosage space, Dw (e.g. the interval [0, 1]). We define the set of all treatment-dosage pairs to be
T = {(w, d) : w ∈ W, d ∈ Dw}.
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Following Rubin’s potential outcome framework (Rubin, 1984), we assume that for all treatment-dosage
pairs, (w, d), there is a potential outcome Y (w, d) ∈ Y (e.g. 1-year survival probability). The observed
outcome is then defined to be Yf = Y (Wf , Df ). We will refer to the unobserved (potential) outcomes as
counterfactuals.
The goal is to derive unbiased estimates of the potential outcomes for a given set of input covariates:
µ(t,x) = E[Y (t)|X = x] (1)
for each t ∈ T , x ∈ X . We refer to µ(·) as the individualised dose-response function. A table summarising
our notation is given in Appendix A. In order to ensure that this quantity is equal to E[Y |X = x, T = t]
and that the dose-response function is identifiable from the observational data, we require the following two
assumptions.
Assumption 1 (Unconfoundedness) The treatment assignment, Tf , and potential outcomes, Y (w, d), are
conditionally independent given the covariates X, i.e.
{Y (w, d)|w ∈ W, d ∈ Dw} ⊥⊥ Tf |X . (2)
Assumption 2 (Overlap) For each x ∈ X such that p(x) > 0, we have 1 > p(t|x) > 0 for each t ∈ T .
3. SCIGAN
We propose estimating µ by first training a generator to generate response curves for each sample within
the training dataset. The learned generator can then be used to train an inference network using standard
supervised methods. We build on the idea presented in Yoon et al. (2018), using a modified GAN framework
to generate potential outcomes conditional on the observed features, treatment and factual outcome. Several
changes must be made to both the generator and discriminator architectures and learning paradigms in order
to produce a model capable of handling the dose-response setting.
3.1 Counterfactual Generator
Our generator, G : X × T × Y × Z → YT takes features, x ∈ X , factual outcome, yf ∈ Y , received
treatment and dosage, tf = (wf , df ) ∈ T , and some noise, z ∈ Z (typically multivariate uniform or
Gaussian), as inputs. The output will be a dose-response curve for each treatment (as shown in Fig. 1), so
that the output is a function from T to Y , i.e. G(x, tf , yf , z)(·) : T → Y . We can then write
yˆcf (t) = G(x, tf , yf , z)(t) (3)
as our generated counterfactual outcome for treatment-dosage pair t. We write Yˆcf (t) = G(X, Tf , Yf ,Z)(t)
(i.e. the random variable induced by G).
While the job of the counterfactual generator is to generate outcomes for the treatment-dosage pairs
which were not observed, Yoon et al. (2018) demonstrated that the performance of the counterfactual
generator is improved by adding a supervised loss term that regularises its output for the factual treatment
(in our case treatment-dosage pair). We define the supervised loss, LS , to be
LS(G) = E
[
(Yf −G(X, Tf , Yf ,Z)(Tf ))2
]
, (4)
where the expectation is taken over X, Tf , Yf and Z.
4
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Figure 2: Overview of our model for the setting with two treatments (wf /wcf being the factual/counterfactual
treatment). The generator is used to generate an output for each dosage level in each D˜w, these outcomes together
with the factual outcome, yf , are used to create the set of dosage-outcome pairs, y˜, which is passed to the treatment
discriminator. Each dosage discriminator receives only the part of y˜ corresponding to that treatment, i.e. y˜w. These
discriminators are combined (Eq. 11) to define DH which gives feedback to the generator.
3.2 Counterfactual Discriminator
As noted in Section 1, our discriminator will act on a random set of points from each of the generated
dose-response curves. Similar to Yoon et al. (2018), we define a discriminator, D, that will attempt to pick
out the factual treatment-dosage pair from among the (random set of) generated ones.
Formally, let nw ∈ Z+ be the number of dosage levels we will compare for treatment w ∈ W2. For each
w ∈ W , let D˜w = {Dw1 , ..., Dwnw} be a random subset3 of Dw of size nw, where for the factual treatment,
Wf , D˜Wf contains nWf−1 random elements along withDf . We define Y˜w = (Dwi , Y˜ wi )nwi=1 ∈ (Dw×Y)nw
to be the vector of dosage-outcome pairs for treatment w where
Y˜ wi =
{
Yf if Wf = w and Df = Dwi
Yˆcf (w,D
w
i ) else
(5)
and will write Y˜ = (Y˜w)w∈W . We will write dwj , y˜w and y˜ to denote realisations of D
w
j , Y˜w and Y˜.
Our discriminator, D : X ×∏w∈W(Dw × Y)nw → [0, 1]∑nw , will take the features x ∈ X together
with the (random) set of generated outcomes y˜ ∈ Y
∑
nw , and output a probability for each treatment-dosage
pair indicating the discriminator’s belief that that pair is the factual one.
As in the standard GAN framework, we define a minimax game by defining the value function to be
L(D,G) = E
[ ∑
w∈W
∑
d∈D˜w
I{Tf=(w,d)} logD
w,d(X, Y˜) + I{Tf 6=(w,d)} log(1−Dw,d(X, Y˜))
]
, (6)
where the expectation is taken over X, Tf , Y˜ and {D˜w : w ∈ W}, Dw,d corresponds to the discriminator
output for treatment-dosage pair (w, d).
2In practice we set all nw to be the same. The default setting is 5 in the experiments.
3In practice, when Dw = [0, 1], each Dwj is sampled independently and uniformly from [0, 1]. Note that for each training
iteration, D˜w is resampled (see Section 1).
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The minimax game is then given by
min
G
max
D
L(D,G) + λLS(G) , (7)
where λ is used to control the trade-off between L and LS (we set λ = 1 in the experiments).
The task of the discriminator (i.e. picking out the factual dosage from
∑k
j=1 nwj treatment-dosage
pairs) becomes increasingly difficult as we increase nw or k because the dimension of the discriminator
output space,
∑
nw, increases. Although we control nw, if we set it too low, then the set y˜w may not
well-represent the dose-response curve, particularly if the dose-response curve is complex. In practice
we found that even for moderate settings of nw and only 2 treatments, modelling the discriminator as a
single function resulted in poor performance. In order to overcome this problem, we introduce a novel
hierarchical discriminator which involves a treatment discriminator with output dimension k and several
dosage discriminators, one for each treatment, with output dimensions nw.
First observe that the probability P((Wf , Df ) = (w, d)|X, D˜w, Y˜) can be written as
P(Wf = w|X, D˜w, Y˜)× P(Df = d|Wf = w,X, D˜w, Y˜) . (8)
We can therefore break down the discriminator into a hierarchical model by learning one discriminator,
DW , that outputs P(Wf = w|X, D˜w, Y˜) which we will refer to as the treatment discriminator, and then a
discriminator, Dw, for each treatment, w ∈ W , that outputs P(Df = d|Wf = w,X, D˜w, Y˜) which we will
refer to as the dosage discriminator for treatment w. Note that although these treatment discriminators are
different functions, we can model (some of) them as a single network if we believe that the response curves
for different treatments are similar or if there is not sufficient data to learn k distinct networks. To do so, we
might use a single network that takes an additional input indicating which treatment the discriminator is for.
This is a modelling choice, and should be driven by knowledge of the problem domain.
The treatment discriminator, DW : X ×
∏
w∈W(Dw × Y)nw → [0, 1]k, takes the features, x, and
generated potential outcomes, y˜, and outputs a probability for each treatment, w1, ..., wk. Writing DwW to
denote the output of DW corresponding to treatment w, we define the loss, LW , to be
LW(DW ;G) = −E
[ ∑
w∈W
I{Wf=w} logD
w
W(X, Y˜) + I{Wf 6=w} log(1−DwW(X, Y˜))
]
, (9)
where, again, the expectation is taken over X,Wf , Df , Y˜ and {D˜w}w∈W .
Then, for each w ∈ W , Dw : X × (Dw × Y)nw → [0, 1]nw is a map that takes the features, x, and
generated potential outcomes, y˜w, corresponding to treatment w and outputs a probability for each dosage
level, dw1 , ..., d
w
nw , in a given realisation of D˜w. Writing Djw to denote the output of Dw corresponding to
dosage level Dwj , we define the loss of each dosage discriminator to be
Ld(Dw;G) = −E
[
I{Wf=w}
nw∑
j=1
I{Df=Dwj } logD
j
w(X, Y˜w) + I{Df 6=Dwj } log(1−Djw(X, Y˜w))
]
, (10)
where the expectation is taken over X, D˜w, Y˜w,Wf and Df . The I{Wf=w} term ensures that only samples
for which the factual treatment is w are used to train dosage discriminator Dw (otherwise there would be
no factual dosage for that sample).
We define the overall discriminator DH : X ×
∏
w∈W(Dw × Y )nw → [0, 1]
∑
nw by defining its output
corresponding to the treatment-dosage pair (w, dwj ) as
Dw,jH (x, y˜) = D
w
W(x, y˜)×Djw(x, y˜w) . (11)
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Instead of the minimax game in Eq. 7, the generator and discriminator are trained according to the
minimax game defined by seeking G∗, D∗H that solve:
G∗ = arg min
G
L(D∗H ;G) + λLS(G) D∗Hw,j = D∗Ww ×D∗wj
D∗W = arg min
DW
LW(DW ;G∗) D∗w = arg min
Dw
Ld(Dw;G∗), ∀w ∈ W (12)
Fig. 2 depicts our generator and hierarchical discriminator. Pseudo-code for our algorithm can be found
in Appendix B.
3.3 Inference Network
Once we have learned the counterfactual generator, we can use it only to access (generated) dose-response
curves for all samples in the dataset. To generate dose-response curves for a new sample we use the
counterfactual generator along with the original data to train an inference network, I : X × T → Y . As
with the training of the generator and discriminator, we train using a random set of dosages, D˜w. The loss is
given by
LI(I) = E
[ ∑
w∈W
∑
d∈D˜w
(Y˜ (w, d)− I(X, (w, d)))2
]
, (13)
where Y˜ (w, d) is Yf if Tf = (w, d) or given by the generator if Tf 6= (w, d). The expectation is taken over
X, Tf , Yf ,Z and D˜w.
4. Theoretical Analysis of SCIGAN
In this section we provide a theoretical analysis of the objective defined by Eq. (7) and establish equivalence
with the game defined by Eqs. (12). Together, the results establish that our hierarchical GAN learns
counterfactuals that agree (in marginal distribution) with the true data.
Lemma 1 Fix G and D˜ = ⋃w D˜w. Let pw,d(y|x) = pr(yw,d|x)pG(y¬w,d|x, yw,d) denote the induced
joint density of outcomes when restricted to dosages in D˜, where pr denotes the true density that generated
the observed outcome and pG denotes the density induced by G over the remaining dosages in D˜. Then the
optimal discriminator is
D∗w,j(x,y) =
p˜(w, dj |x)pw,dj (y|x)∑
w′∈W
∑nw
i=1 p˜(w
′, di|x)pw′,di(y|x)
(14)
where p˜ is the D˜-restricted propensity given by p˜(w, dj |x) = p(w|x)(p(dj |x, w)/
∑nw
i=1 p(di|x, w)).
Proof Fix G and D˜ = ⋃w D˜w. The optimal discriminator is given by arg minD L(D,G). We have
L(D,G) = E
[ ∑
w∈W
∑
d∈D˜w
I{Tf=(w,d)} logD
w,d(X, Y˜) + I{Tf 6=(w,d)} log(1−Dw,d(X, Y˜))
]
(15)
= ED˜
[ ∑
w∈W
∑
d∈D˜w
∫
(x,y)
p˜(w, d|x)pw,d(y|x) logDw,d(x,y)
+
( ∑
w′,d′ 6=w,d
p˜(w′, d′|x)pw′,d′(y|x)
)
log(1−Dw,d(x,y))p(x)dydx
] (16)
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where we have taken the (conditional on D˜) expectations inside the sums and replaced indicator functions
with densities as appropriate. We now note that a log p+ b log(1− p) for p ∈ (0, 1) has a unique maximum
at p = aa+b , thus implying that the integrand is maximised when
Dw,d(x,y) =
p˜(w, d|x)pw,d(y|x)
p˜(w, d|x)pw,d(y|x) +
∑
w′,d′ 6=w,d p˜(w′, d′|x)pw′,d′(y|x)
. (17)
This gives the required result.
Using Lemma 1 we can now prove the key result, which establishes that the marginal distributions of
our counterfactuals will be correct when estimated using our GAN framework. Importantly, this suffices for
estimating µ since the expectation is only concerned with the marginal distribution of Y (w, d).
Theorem 1 The global minimum of the minimax game defined by minG maxD L(D,G) is achieved if and
only if for all D˜w, for all w,w′ ∈ W and for all d ∈ D˜w, d′ ∈ D˜w′
pw,d(y|x) = pw′,d′(y|x) (18)
which in turn implies that for any (w, d) ∈ T we have that the generated counterfactual for outcome (w, d)
for any sample (that was not assigned (w, d)) has the same (marginal) distribution (conditional on the
features) as the true marginal distribution for that outcome.
Proof For fixed D˜ and xwe note that by substituting the optimal discriminator intoL(D,G) and subtracting∑
w∈W
∑nw
i=1 log p˜(w, di|x) (which is independent of G) we obtain
L(D∗,G)−
∫
x
( ∑
w∈W
nw∑
i=1
log p˜(w, di|x)
)
p(x)dx
= ED˜
∫
x
KL
(
pw,d(y|x)||pˆ(y|x)
)
+ KL
( 1
1− p˜(w, d|x)
∑
t′ 6=(w,d)
p˜(t′|x)pt′(y|x)||pˆ(y|x)
)
dx . (19)
where KL is the KL divergence and pˆ(y|x) = ∑t∈T˜ p˜(t|x)pt(y|x) where T˜ is the restriction of T to the
dosages in D˜. We then note that that the KL divergence is minimised if and only if the two densities are
equal, and we note by definition of pˆ this occurs if and only if pw,d(y|x) = pw′,d′(y|x) for all w, d,w′, d′.
This also directly implies that the marginal distributions for any fixed treatment-dosage pair agree for all
factually observed treatments. In particular, if a sample received treatment t′ 6= t, we have that the counter-
factual generated for t for this sample has the same distribution as the true data generating distribution.
Our final theorem establishes equivalence between the hierarchical discriminator and the single discrim-
inator setup under a mild assumption that can be satisfied by, say, resampling the noise for each treatment
or passing independent noise samples to each multi-task head.
Theorem 2 The game defined by Eqs. 12 is equivalent to the one defined by Eq. 7 if the response curves
generated by the generator for different treatments are conditionally independent given the features.
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Proof To prove this result, it suffices to show that for fixed G, D∗H = D
∗. To show this, we observe that
by the same arguments as given for Lemma 1, we have the following:
DwW
∗(x,y) =
p(w|x)
(∑nw
i=1 p˜(di|x, w)pw,di(y|x)
)
∑
w′∈W
(
p(w′|x)∑nwi=1 p˜(di|x, w)) (20)
Djw
∗
(x,yw) =
p˜(dj |x, w)pw,dj (yw|x)∑nw
i=1 p˜(di|x, w)pw,di(yw|x)
(21)
where yw is the restriction of y to the outcomes corresponding to treatment w. By multiplying (21) by
pw,dj (y 6=w|y,x)
pw,dj (y 6=w|y,x)
we obtain
Djw
∗
(x,yw) =
p˜(dj |x, w)pw,dj (y|x)∑nw
i=1 p˜(di|x, w)pw,di(y|x)
(22)
since the conditional independence assumption implies that pw,dj (y 6=w|y,x) = pw,di(y 6=w|y,x) for all
i, j = 1, ..., nw. Multiplying (20) and (22) together to get D
w,j
H , we notice that the denominator in (22)
cancels with the bracketed term of the numerator in (20) to give
D∗H
w,j =
p(w|x)p˜(dj |x, w)pw,dj (y|x)∑
w′∈W
(
p(w′|x)∑nwi=1 p˜(di|x, w)) (23)
=
p˜(w, dj |x)pw,dj (y|x)∑
w′∈W
∑nw
i=1 p˜(w
′, di|x)pw′,di(y|x)
(24)
which is equal to the optimal discriminator for the single loss given in Lemma 1.
5. Architecture
In this section, we describe in detail the novel architectures that we adopt to model each of the functions
G,D,DW ,Dw1 , ...,Dwk which draws from the ideas in Zaheer et al. (2017). The inference network, I,
has the same architecture as the generator, but does not receive wf , df , yf or z as inputs.
5.1 Generator Architecture
We adopt a multi-task deep learning model for G by defining a function g : X × T × Y × Z → H for
some latent spaceH (typically Rl for some l) and then for each treatment w ∈ W we introduce a multitask
“head", gw : H × Dw → Y taking inputs from H and a dosage, d, to produce an outcome yˆ(w, d) ∈ Y .
Given observations, (x, tf , yf ), a noise vector z, and a target treatment-dosage pair, t = (w, d), we define
G(x, tf , yf , z)(t) = gw(g(x, tf , yf , z), d) . (25)
Each of g, gw1 , ..., gwk are fully connected networks. A figure of our generator architecture is given in
Figure 3(a).
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Figure 3: Architecture of our generator and discriminators.
5.2 Discriminator Architectures
As noted in Section 1, our discriminators need to act as functions of sets (of randomly selected dosage-
outcome pairs). While we could require that our discriminators try to learn this during training, by
enforcing them to be functions of sets through their architecture, we reduce the complexity of learning the
discriminators (they no longer need to “rule out" functions which are not functions of sets). This results in
better performing discriminators, which in turn improves the performance of the generator.
In practice, the treatment discriminator receives all of the sets (i.e. one set for each treatment) of
dosage-outcome pairs and outputs a probability for each treatment (i.e. there is one output corresponding to
each set). In order to define such a function, we treat each input set as a vector but require that the outputs
be invariant to (i.e. should not depend on) the ordering of the set as a vector. Each dosage discriminator
receives the set corresponding to a given treatment and is tasked with outputting a probability for each
element in the set. In order to define such a function, we consider the input and output as vectors but then
require that if we permute the elements of the input vector, the output should be permuted in the same way.
5.2.1 PERMUTATION INVARIANCE AND PERMUTATION EQUIVARIANCE
The notions of what it means for a function to be permutation invariant and permutation equivariant with
respect to (a subset of) its inputs are given below in definitions 1 and 2, respectively. Let U , V , C be some
spaces. Let m ∈ Z+.
Definition 1 A function f : Um×V → C is permutation invariant with respect to the space Um if for every
u = (u1, ..., um) ∈ Um, every v ∈ V and every permutation, σ, of {1, ...,m} we have
f(u1, ..., um, v) = f(uσ(1), ..., uσ(m), v) . (26)
Definition 2 A function f : Um × V → Cm is permutation equivariant with respect to the space Um if
for every u ∈ Um, every v ∈ V and every permutation, σ, of {1, ...,m} we have f(uσ(1), ..., uσ(m), v) =
(fσ(1)(u, v), ..., fσ(m)(u, v)), where fj(u, v) is the jth element of f(u, v).
To build up functions that are permutation invariant and permutation equivariant we make the following
observations: (1) the composition of any function with a permutation invariant function is permutation
invariant, (2) the composition of two permutation equivariant functions is permutation equivariant.
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Zaheer et al. (2017) provide several possible building blocks to use to construct invariant and equivariant
deep networks. The basic building block we will use for invariant functions will be a layer of the form
finv(u) = σ(1b1
T
m(φ(u1), ..., φ(um))) , (27)
where 1l is a vector of 1s of dimension l, φ is any function φ : U → Rq for some q (in this paper we use a
standard fully connected layer) and σ is some non-linearity.
The basic building block for equivariant functions is defined in terms of equivariance input, u, and
auxiliary input, v, by
fequi(u,v) = σ(λImu+ γ(1m1
T
m)u+ (1mΘ
T )v) , (28)
where Im is the m×m identity matrix, λ and γ are scalar parameters and Θ is a vector of weights.
5.2.2 HIERARCHICAL DISCRIMINATOR ARCHITECTURE
In the case of the hierarchical discriminator, we want the treatment discriminator, DW , to be permutation
invariant with respect to y˜w for each treatment. To achieve this we define h1 :
∏
w∈W(Dw × Y)nw → HH
and require that h1 be permutation invariant w.r.t. each of the spaces (Dw × Y)nw . We concatenate the
output of h1 with the features x and pass these through a fully connected network h2 : X ×HH → [0, 1]k
so that DW(x, y˜) = h2(x, h1(y˜)).
To construct h1, we concatenate the outputs of several invariant layers of the form given in Eq. (27)
that each individually act on the spaces (Dw × Y)nw . That is, for each treatment, w ∈ W we define a map
hwinv : (Dw × Y)nw → HwH by substituting y˜w for u in Eq. (27). We then define HH =
∏
w∈W HwH and
h1(y˜) = (h
w1
inv(y˜w1), ..., h
wk
inv(y˜wk)).
We want each dosage discriminator, Dw, to be permutation equivariant with respect to y˜w. To achieve
this each Dw will consist of two layers of the form given in Eq. (28) with the equivariance input, u, to the
first layer being y˜w and to the second layer being the output of the first layer and the auxiliary input, v, to
the first layer being the features, x, and then no auxiliary input to the second layer. Diagrams depicting the
architectures of the treatment discriminator and dosage discriminators can be found in Fig. 3(b) and Fig.
3(c) respectively.
6. Related work
Methods for estimating the outcomes of treatments with a continuous dosage from observational data make
use of the generalized propensity score (GPS) (Imbens, 2000; Imai and Van Dyk, 2004; Hirano and Imbens,
2004) or build on top of balancing methods for multiple treatments. Schwab et al. (2019) developed a neural
network based method to estimate counterfactuals for multiple treatments and continuous dosages. The
proposed Dose Response networks (DRNets) in Schwab et al. (2019) consist of a three level architecture
with shared layers for all treatments, multi-task layers for each treatment and additional multi-task layers
for dosage sub-intervals. Specifically, for each treatment w, the dosage interval [aw, bw] is subdivided into
E equally sized sub-intervals and a multi-task head is added for each sub-interval. This is an extension
of the architecture in Shalit et al. (2017). However, the main advantage of using multi-task heads for
dosage intervals would be the added flexibility in the model to learn potentially very different functions
over different regions of the dosage interval. DRNets do not determine these intervals dynamically and
thus much of this flexbility is lost. Our approach (using GANs to generate counterfactuals) fundamentally
differs from DRNets (supervised learning with bias-adjustment) and we demonstrate experimentally that
SCIGAN outperforms both GPS and DRNets.
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Most methods for performing causal inference in the static setting focus on the scenario with two or
multiple treatment options and no dosage parameter. The approaches taken by such methods to estimate the
treatment effects involve either building a separate regression model for each treatment (Stoehlmacher et al.,
2004; Qian and Murphy, 2011; Bertsimas et al., 2017) or using the treatment as a feature and adjusting for
the imbalance between the different treatment populations. The former does not generalise to the dosage
setting due to the now infinite number of possible treatments available. Note also that treating the dosage as
an input does not account for the bias in the dosage parameter. In the latter case, methods for handling the
selection bias involve propensity weighting (Crump et al., 2008; Alaa et al., 2017; Shi et al., 2019), building
sub-populations using tree based methods (Chipman et al., 2010; Athey and Imbens, 2016; Wager and
Athey, 2018; Kallus, 2017) or building balancing representations between patients receiving the different
treatments (Johansson et al., 2016; Shalit et al., 2017; Li and Fu, 2017; Yao et al., 2018). An additional
approach involves modelling the data distribution of the factual and counterfactual outcomes (Alaa and
van der Schaar, 2017; Yoon et al., 2018).
Silva (2016) leverages observational and interventional data to estimate the effects of discrete dosages
for a single treatment. In particular, Silva (2016) uses observational data to construct a non-stationary
covariance function and develop a hierarchical Gaussian process prior to build a distribution over the dose
response curve. Then, controlled interventions are employed to learn a non-parametric affine transform to
reshape this distribution. The setting in Silva (2016) differs significantly from ours as we do not assume
access to any interventional data.
7. Evaluation
The nature of the treatment-effects estimation problem in even the binary treatments setting does not allow
for meaningful evaluation on real-world datasets due to the inability to observe the counterfactuals. While
there are well-established benchmark synthetic models for use in the binary (or multiple) case, no such
models exist for the dosage setting. We propose our own semi-synthetic data simulation to evaluate our
model against several benchmarks.
7.1 Experimental setup
7.1.1 SEMI-SYNTHETIC DATA GENERATION
We simulate data as follows. We obtain features, x, from a real dataset (in this paper we use TCGA
(Weinstein et al., 2013), News (Johansson et al., 2016; Schwab et al., 2019)) and MIMIC III (Johnson et al.,
2016))4. We consider 3 treatments each accompanied by a dosage. Each treatment, w, is associated with a
set of parameters, vw1 ,v
w
2 , v
w
3 . For each run of the experiment, these parameters are sampled randomly
by sampling a vector, uwi , from N (0,1) and then setting vwi = uwi /||uwi || where || · || is Euclidean norm.
The shape of the response curve for each treatment, fw(x, d), is given in Table 1, along with a closed-form
expression for the optimal dosage. We add  ∼ N (0, 0.2) noise to the outcomes.
We assign interventions by sampling a dosage, dw, for each treatment from a beta distribution
dw|x ∼ Beta(α, βw) . (29)
α ≥ 1 controls the selection bias. We set βw = α−1d∗w + 2− α where d
∗
w is the optimal dosage for treatment
w (which is a function of x). This setting of βw ensures that the mode of our distribution is d∗w, and we can
4Details of each dataset can be found in Appendix E
12
write the variance of dw in terms of α and d∗w as follows
Var(dw) =
α2−α
d∗w
+ 2α− α2
(α−1d∗w + 2)
2(α−1d∗w + 3)
≈ cα
2
dα3
. (30)
We see that the variance of our Beta distribution therefore decreases with α, resulting in the sampled
dosages being closer to the optimal dosage, thus resulting in higher dosage-selection bias. In addition we
note that the Beta(1, 1) distribution is the uniform distribution, corresponding to the dosages being sampled
independently of the patient features, resulting in no selection bias when α = 1. Note that when d∗w = 0,
for symmetry, we sample dw from 1− Beta(α, βw) where βw is set as though d∗w = 1.
Given a selected dosage for each treatment, we assign a treatment according to
wf |x ∼ Categorical(softmax(κf(x, dw)) (31)
where increasing κ increases selection bias, and κ = 0 leads to random assignments. The factual intervention
is given by (wf , dwf ). Unless otherwise specified, we set κ = 2 and α = 2.
We consider 3 shapes for fw to demonstrate learning heterogeneous response curves. The first curve
can be broken down into two terms, a linear (in d) increasing term (v11)
Tx+ 12(v12)
Txd and a quadratic (in
d) decreasing term −12(v13)Txd2. This first term could represent the improved efficacy of higher dosages
of chemotherapy in reducing tumour size, while the quadratic term could represent the increasing toxicity
of chemotherapy as the dosage increases. This type of trade-off presents itself in many other settings.
Treatment Dose-Response Optimal dosage
1 f1(x, d) = C((v11)
Tx+ 12(v12)
Txd− 12(v13)Txd2) d∗1 = (v
1
2)
Tx
2(v13)
Tx
2 f2(x, d) = C((v21)
Tx+ sin(pi(
v22
T
x
v23
Tx
)d)) d∗2 =
(v23)
Tx
2(v22)
Tx
3 f3(x, d) = C((v31)
Tx+ 12d(d− b)2, where b = 0.75 (v32)Tx
(v33)
Tx
)
b
3 if b ≥ 0.75
1 if b < 0.75
Table 1: Dose response curves used to generate semi-synthetic outcomes for patient features x. In the experiments,
we set C = 10. vw1 ,v
w
2 , v
w
3 are the parameters associated with each treatment w.
7.1.2 BENCHMARKS
We compare against two benchmarks: Generalized Propensity Score (GPS) (Imbens, 2000) and Dose
Reponse Networks (DRNet) (Schwab et al., 2019) (the standard model and with Wasserstein regularization
(DRN-W)). As a baseline, we compare against a standard multilayer perceptron (MLP) that takes patient
features, treatment and dosage as input and estimates the patient outcome and a multitask variant (MLP-M)
that has a designated head for each treatment. See Appendix F for details of the benchmark models and
their hyperparameter optimisation.
7.1.3 METRICS
For metrics, we use Mean Integrated Square Error (MISE), Dosage Policy Error (DPE) and Policy Error
(PE) (Silva, 2016; Schwab et al., 2019). Each of these metrics are computed on a held out test-set.
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The Mean Integrated Square Error (MISE) measures how well a model estimates the patient outcomes
across the entire dosage space:
MISE =
1
N
1
k
∑
w∈W
N∑
i=1
∫
Dw
(
yi(w, u)− yˆi(w, u)
)2
du . (32)
The mean dosage policy error (DPE) (Schwab et al., 2019) assesses the ability of a model to estimate
the optimal dosage point for every treatment for each individual:
DPE =
1
N
1
k
∑
w∈W
N∑
i=1
(
yi(w, d∗w)− yi(w, dˆ∗w)
)2
, (33)
where d∗w is the true optimal dosage and dˆ∗w is the optimal dosage identified by the model. The optimal
dosage points for a model are computed using SciPy’s implementation of Sequential Least SQuares
Programming.
Finally, the mean policy error (PE) (Schwab et al., 2019) compares the outcome of the true optimal
treatment-dosage pair to the outcome of the optimal treatment-dosage pair as selected by the model:
PE =
1
N
N∑
i=1
(
yi(w∗, d∗w)− yi(wˆ∗, dˆ∗w)
)2
, (34)
where w∗ is the true optimal treatment and wˆ∗ is the optimal treatment identified by the model. The
optimal treatment-dosage pair for a model is selected by first computing the optimal dosage for each
treatment and then selecting the treatment with the best outcome for its optimal dosage.
7.2 Source of gain
Before comparing against the benchmarks, we investigate how each component of our model affects
performance. We start with a baseline model in which both the generator and discriminator consist of a
single fully connected network. One at a time, we add in the following components (cumulatively until
we reach our full model): (1) the supervised loss in Eq. 4 (+ LS), (2) multitask heads in the generator (+
Multitask), (3) hierarchical discriminator (+ Hierarchical) and (4) invariance/equivariance layers in the
treatment and dosage discriminators (+Inv/Eqv). We report the results in Table 2 for TCGA and News for
all 3 error metrics (MISE, DPE and PE), computed over 30 runs.
TCGA News√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
Baseline 4.18± 0.32 2.06± 0.16 1.93± 0.12 6.17± 0.27 6.97± 0.27 6.20± 0.21
+ LS 3.37± 0.11 1.14± 0.05 0.84± 0.05 4.51± 0.16 4.46± 0.12 4.40± 0.11
+ Multitask 3.15± 0.12 0.85± 0.05 0.67± 0.05 4.11± 0.11 4.33± 0.11 4.31± 0.11
+ Hierarchical 2.54± 0.05 0.36± 0.05 0.45± 0.05 4.07± 0.05 4.24± 0.11 4.17± 0.12
+ Inv/Eqv 1.89± 0.05 0.31± 0.05 0.25± 0.05 3.71± 0.05 4.14± 0.11 3.90± 0.05
Table 2: Source of gain analysis for our model. Metrics are reported as Mean ± Std.
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The addition of each component results in improved performance, with the final row (our full model)
demonstrating the best performance across both datasets and for all metrics. In Appendix G we further
compare our hierarchical discriminator with a single network discriminator by investigating both models
sensitivity to the hyperparameter nw. Details of the single discriminator can be found in Appendix D.
7.3 Benchmarks comparison
We now compare SCIGAN against the benchmarks on our 3 semi-synthetic datasets. For MIMIC, due to
the low number of samples available, we use two treatments - 2 and 3. We report each metric in Table 3.
We see that SCIGAN demonstrates a significant improvement over every benchmark across all 3 datasets.
In section 7.6 we compare SCIGAN with DRNET and GPS for an increasing number of treatments.
Method TCGA News MIMIC√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
SCIGAN 1.89± 0.05 0.31± 0.05 0.25± 0.05 3.71± 0.05 4.14± 0.11 3.90± 0.05 2.09± 0.12 0.51± 0.05 0.32± 0.05
DRNet 3.64± 0.12 0.51± 0.05 0.67± 0.05 4.98± 0.12 4.39± 0.11 4.17± 0.11 4.45± 0.12 0.52± 0.05 1.44± 0.05
DRN-W 3.71± 0.12 0.50± 0.05 0.63± 0.05 5.07± 0.12 4.21± 0.11 4.56± 0.12 4.47± 0.12 0.53± 0.05 1.37± 0.05
GPS 4.83± 0.01 1.38± 0.01 1.60± 0.01 6.97± 0.01 6.40± 0.01 24.1± 0.05 7.39± 0.00 1.41± 0.12 20.2± 0.01
MLP-M 3.96± 0.12 0.92± 0.05 1.20± 0.05 5.17± 0.12 4.94± 0.16 5.82± 0.16 4.97± 0.16 0.77± 0.05 1.59± 0.05
MLP 4.31± 0.05 1.04± 0.05 0.97± 0.05 5.48± 0.16 5.18± 0.12 6.45± 0.21 5.34± 0.16 0.80± 0.05 1.65± 0.05
Table 3: Performance of individualized treatment-dose response estimation on three datasets. Bold indicates the
method with the best performance for each dataset. Metrics are reported as Mean ± Std.
7.4 Discrete dosages
In this experiment, we investigate the discrete dosage setting. In this set-up, we use the TCGA dataset and
treatments 2 and 3 from Table 1 with dose-response curves f2(x, d) and f3(x, d) respectively. Let β be the
number of discrete dosages for which we want to generate data. We chose β equally spaced points in the
interval [0, 1] as our set of discrete dosages: ∆ = { kβ−1}β−1k=0 . To create factual dosages for our dataset, we
sample the dosages as before dw | x ∼ Beta(α, βw), and choose the closest discrete dosage from the set ∆.
To evaluate SCIGAN in this setting, we maintain the same architecture for the multi-task generator and
hierarchical discriminator. The only difference is that we now randomly sample dosages for the SCIGAN
discriminator from ∆.
We adopt the GANITE implementation proposed by Yoon et al. (2018). To be able to have a fair
comparison with SCIGAN we also use a multi-task architecture for the GANITE generator and we give
as input to each multitask head the dosage parameter. The GANITE generator will generate outcomes for
all possible discrete dosages in ∆ and these will be passed to the GANITE discriminator to distinguish
the factual one. For the GANITE generator we use a similar architecture to the SCIGAN generator with 2
hidden layers for each multitask head and 64 neurons in each layer. The GANITE discriminator consists
of 2 fully connected layers with 64 neurons in each. We also set λ = 1. In addition, to maintain a similar
set-up to SCIGAN, we train an inference network to learn the counterfactual outcomes with data from the
GANITE generator. The inference network has the same architecture as the GANITE generator. We report
the Mean Squared Error (MSE), DPE and PE of SCIGAN and GANITE in Fig. 4 where we vary the number
of discrete dosages from 3 to 30.
We clearly see from Fig. 4 that SCIGAN achieves a similar performance to GANITE for a small
number of dosages (< 6) but then significantly outperforms GANITE for more dosages than 6. In fact,
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Figure 4: Comparison between SCIGAN and GANITE in the discrete dosage set-up.
we see that while GANITE’s performance degrades with an increasing number of dosages, SCIGAN’s
improves and then stabilises at around 12 dosages. This is due to the fact that the single discriminator in
GANITE simply cannot handle a large number of dosages. Our hierarchical model, however, can. The
worse performance of SCIGAN for the lower dosages can be attributed to the fact that for such few dosages
(e.g. 3 dosages corresponds to only 6 total different interventions), the SCIGAN architecture is overly
complex, and the sub-sampling of dosages for the discriminator is not actually necessary. These results
demonstrate SCIGAN’s wide-ranging applicability in both discrete and continuous settings.
7.5 Mixing dosage and no-dosage treatment options
We also evaluate the case when one of the treatments does not have a dosage parameter. For this experiment
we generate data for the treatment that has a dosage parameter d using f3(x, d) and for the treatment
without an associated dosage using 2C(vT0 x), where v0 are parameters, x are patient features and C = is
the scaling parameter. This set-up also corresponds to the scenario where we want to compare giving a
treatment with a dosage and not giving any treatment.
SCIGAN can be easily extended to incorporate an additional treatment that does not come with a
dosage parameter. Such treatments will not need a dosage discriminator but will be passed to the treatment
discriminator. A head can be added to the generator for each such non-dosage treatment but will not need to
take dosage as an input. As the DRNet public implementation does not allow for this set-up, we compared
SCIGAN with the multilayer perceptron model with multitask heads (MLP-M). This model is trained using
supervised learning to minimize error on the factual outcomes and consists of two multitask heads: one
head for the treatment option which receives as input the dosage and estimates the dose-response curve and
one head for the no-treatment option.
As can be seen in Table 4, SCIGAN is capable of handling this setting and lends itself naturally to
potentially mixed dosage and no-dosage treatment options.
Method TCGA News MIMIC√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
SCIGAN 1.28± 0.09 1.37± 0.07 1.56± 0.06 3.18± 0.15 2.04± 0.09 2.49± 0.12 0.61± 0.08 1.82± 0.02 1.89± 0.03
MLP-M 2.08± 0.12 1.85± 0.16 2.02± 0.07 4.68± 0.11 2.45± 0.08 2.64± 0.08 1.56± 0.08 2.04± 0.03 2.14± 0.5
Table 4: Performance of individualized treatment-dose response when mixing treatment with no-treatment options.
Bold indicates the method with the best performance for each dataset.
16
7.6 Varying the number of treatments
In this experiment, we increase the number of treatments by defining 3 or 6 additional treatments. The
parameters vw1 ,v
w
2 ,v
w
3 are defined in exactly the same way as for 3 treatments. The outcome shapes for
treatments 4 and 7 are the same as for treatment 1, similarly for 5, 8 and 2 and for 6, 9 and 3. In Table 5
we report MISE, DPE and PE on the TCGA dataset with 6 treatments (TCGA-6) and with 9 treatments
(TCGA-9). Note that we use 3 dosage samples for training SCIGAN in this experiment.
Method TCGA - 6 TCGA - 9√
MISE
√
DPE
√
PE
√
MISE
√
DPE
√
PE
SCIGAN 2.37± 0.12 0.43± 0.05 0.32± 0.05 2.79± 0.05 0.51± 0.05 0.54± 0.05
DRNET 4.09± 0.16 0.52± 0.05 0.71± 0.05 4.31± 0.12 0.59± 0.05 0.74± 0.05
GPS 6.62± 0.01 2.04± 0.01 2.61± 0.00 7.58± 0.01 3.14± 0.01 2.91± 0.01
Table 5: Performance of SCIGAN and the benchmarks when we increase the number of treatments in the dataset to 6
and 9. Bold indicates the method with the best performance for each dataset.
7.7 Treatment and dosage selection bias
Finally, we assess each model’s robustness to treatment and dosage bias. Fig. 5(a) shows the performance of
the 4 methods for κ between 0 (no bias) and 10 (strong bias). Fig. 5(b) shows the performance for α between
1 (no bias) and 8 (strong bias). SCIGAN shows consistent performance, significantly outperforming the
benchmarks for all κ and α.
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Figure 5: Performance of the 4 methods on datasets with varying bias levels.
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8. Conclusion
In this paper we proposed a novel framework for estimating response curves for continuous interventions
from observational data. We provided theoretical justification for our use of a modified GAN framework,
which introduced a novel hierarchical discriminator. We also proposed novel architectures and introduced
a new semi-synthetic data simulation for use as a benchmark. On this data we demonstrated significant
improvements over the benchmarks.
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Appendix A. Notation
In the table below, we summarise the notation used in our paper. Note that realisations of random variables
are denoted using lowercase and subscripts/superscripts used with vector-valued functions denotes their
output at the position of the given subscript/superscript.
X Feature space
Y Outcome space
T Intervention space
W = {w1, ..., wk} Set of treatments
Dw Dosage space for treatment w ∈ W
X ∈ X Features (random variable)
Y : T → Y Potential outcome function (function-valued random variable)
Tf = (Wf , Df ) ∈ T Factual/observed intervention (treatment-dosage pair) (random variable)
Yf ∈ Y Outcome corresponding to the observed intervention (Yf = Y (Wf , Df ))
G Generator
Z Random noise (for input to generator) (random variable)
Yˆcf : T → Y Counterfactual outcome function induced by G
D Discriminator
D˜w = {Dw1 , ..., Dwnw} Random (finite) subset of Dw
nw = |D˜w| Number of dosage levels passed to discriminator for treatment w ∈ W)
Y˜w = (D
w
i , Y˜
w
i )
nw
i=1 Vector of dosage-outcome pairs generated by G (and Yf ) using D˜w
DW Treatment discriminator
Dw Dosage discriminator for treatment w ∈ W
DH Hierarchical discriminator defined by combining DW and Dw
I Inference network
L GAN loss
LS Supervised loss
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Appendix B. Counterfactual Generator Pseudo-code
Algorithm 1 Training of the generator in SCIGAN
1: Input: dataset C = {(xi, tif , yif ) : i = 1, ..., N}, batch size nmb, number of dosages per treatment
nd, number of discriminator updates per iteration nD, number of generator updates per iteration nG,
dimensionality of noise nz , learning rate α
2: Initialize: θG, θW , {θw}w∈W
3: while G has not converged do
4: Discriminator updates
5: for i = 1, ..., nD do
6: Sample (x1, (w1, d1), y1), ..., (xnmb , (wnmb , dnmb), ynmb) from C
7: Sample generator noise zj = (z
j
1, ..., z
j
nz) from Unif([0, 1]nz) for j = 1, ..., nmb
8: for w ∈ W do
9: for j = 1, ..., nmb do
10: Sample D˜jw = (d
w,j
1 , ..., d
w,j
nd ) independently and uniformly from (Dw)nd
11: Set y˜jw according to Eq. 5
12: end for
13: Calculate gradient of dosage discriminator loss
gw ← ∇θw −
 ∑
{j:wj=w}
nd∑
k=1
I{dj=dw,jk } logDw(xj , y˜
j
w) + I{dj 6=dw,jk } log(1−Dw(xj , y˜
j
w))

14: Update dosage discriminator parameters θw ← θw + αgw
15: end for
16: Set y˜j = (y˜
j
w)w∈W
17: Calculate gradient of treatment discriminator loss
gW ← ∇θW −
nmb∑
j=1
∑
w∈W
I{wj=w} logDW(xj , y˜j) + I{wj 6=w} log(1−DW(xj , y˜j))

18: Update treatment discriminator parameters θW ← θW + αgW
19: end for
20: Generator updates
21: for i = 1, ..., nG do
22: Sample (x1, (w1, d1), y1), ..., (xnmb , (wnmb , dnmb), ynmb) from C
23: Sample generator noise zj = (z
j
1, ..., z
j
nz) from Unif([0, 1]nz) for j = 1, ..., nmb
24: Sample (D˜jw)w∈W from Πw∈W(Dw)nd for j = 1, ..., nmb
25: Set y˜ according to Eq. 5
26: Calculate gradient of generator loss
gG ← ∇θG
[
nmb∑
j=1
∑
w∈W
nd∑
l=1
I{wj=w,dj=dw,jl } log(D
w
W(xj , y˜j)w ×Dlw(xj , y˜jw)l)
+I{wj 6=w,dj 6=dw,jl } log(1− (D
w
W(xj , y˜j)×Dlw(xj , y˜jw)))
]
27: Update generator parameters θG ← θG + αgG
28: end for
29: end while
30: Output: G
Appendix C. Inference Network Pseudo-code
Algorithm 2 Training of the inference network in SCIGAN
1: Input: dataset C = {(xi, tif , yif ) : i = 1, ..., N}, trained generator G, batch size nmb, number of
dosages per treatment nd, dimensionality of noise nz , learning rate α
2: Initialize: θI
3: while I has not converged do
4: Sample (x1, (w1, d1), y1), ..., (xnmb , (wnmb , dnmb), ynmb) from C
5: Sample generator noise zj = (z
j
1, ..., z
j
nz) from Unif([0, 1]nz) for j = 1, ..., nmb
6: for j = 1, ..., nmb do
7: for w ∈ W do
8: Sample D˜jw = (d
w,j
1 , ..., d
w,j
nd ) independently and uniformly from (Dw)nd
9: Set y˜jw according to Eq. 5
10: end for
11: end for
12: Calculate gradient of inference network loss
gI ← −∇θI
[
nmb∑
j=1
∑
w∈W
nd∑
l=1
(y˜jw)l − I(xj , (w, dw,jl ))2
]
13: Update inference network parameters θI ← θI + αgI
14: end while
15: Output: I
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Appendix D. Single Discriminator Model
In the paper we developed a hierarchical discriminator and demonstrated that it performs significantly better
than the single discriminator setup that we now describe in this section.
D.1 Single Discriminator
In the single model, we will aim to learn a single discriminator,D, that outputs P((Wf , Df ) = (w, d)|X, D˜w, Y˜)
for each w ∈ W and d ∈ D˜w. We will write Dw,d(·) to denote the output of D that corresponds to the
treatment-dosage pair (w, d). We define the loss, LD, to be
LD(D;G) = −E
[ ∑
w∈W
∑
d∈D˜w
I{Tf=(w,d)} logD
w,d(X, Y˜) + I{Tf 6=(w,d)} log(1−Dw,d(X, Y˜))
]
(35)
where the expectation is taken over X, {D˜w}w∈W , Y˜,Wf and Df and we note that the dependence on G is
through Y˜. Our single discriminator will be trained to minimise this loss directly. The generator GAN-loss,
LG, is then defined by
LG(G) = −LD(D∗;G) (36)
where D∗ is the optimal discriminator given by minimising LD. The generator will be trained to minimise
LG + λLS .
D.2 Single Discriminator Architecture
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Figure 6: Overview of the single discriminator archi-
tecture.
In the case of the single discriminator, we want the out-
put of D corresponding to each treatment w ∈ W , i.e.
(Dw,1, ...,Dw,nw), to be permutation equivariant with
respect to y˜w and permutation invariant with respect
to each y˜v for v ∈ W \ {w}. To achieve this, we
first define a function f :
∏
w∈W(Dw × Y)nw → HS
and require that this function be permutation invariant
with respect to each of the spaces (Dw × Y)nw . For
each treatment, w ∈ W , we introduce a multitask head,
fw : X ×HS×(Dw×Y)nw → [0, 1]nw , and require that
each of these functions be permutation equivariant with
respect to their corresponding input space (Dw × Y)nw
but they can depend on the features, x ∈ X , and in-
variant latent representation coming from f arbitrarily.
Writing f jw to denote the jth output of fw, the output of
the discriminator given input features, x, and generated
outcomes, y˜, is defined by
Dw,j(x, y˜) = f iw(x, f(y˜), y˜w). (37)
To construct the function f , we concatenate the outputs of several invariant layers of the form given in
Eq. (27) that each individually act on the spaces (Dw×Y)nw . That is, for each treatment, w ∈ W we define
a map fwinv : (Dw × Y)nw → HwS by substituting y˜w for u in Eq. (27). We then defineHS =
∏
w∈W HwS
and f(y˜) = (fw1inv(y˜w1), ..., f
wk
inv(y˜wk)).
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Each fw will consist of two layers of the form given in Eq. (28) with the equivariance input, u, to first
layer being y˜w and to the second layer being the output of the first layer and the auxiliary input, v, to the
first layer being the concatenation of the features and invariant representation, i.e. (x, f(y˜)) and then no
auxiliary input to the second layer.
A diagram depicting the architecture of the single discriminator model can be found in Fig. 6.
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Appendix E. Dataset descriptions
TCGA: The TCGA dataset consists of gene expression measurements for cancer patients (Weinstein et al.,
2013). There are 9659 samples for which we used the measurements from the 4000 most variable genes.
The gene expression data was log-normalized and each feature was scaled in the [0, 1] interval. Moreover,
for each patient, the features x were scaled to have norm 1. We give meaning to our treatments and dosages
by considering the treatment as being chemotherapy/radiotherapy/immunotherapy and their corresponding
dosages. The outcome can be thought of as the risk of cancer recurrence (Schwab et al., 2019).
News: The News dataset consists of word counts for news items. We extracted 10000 samples each
with 2858 features. As in (Johansson et al., 2016; Schwab et al., 2019), we give meaning to our treatments
and dosages by considering the treatment as being the viewing device (e.g. phone, tablet etc.) used to read
the article and the dosage as being the amount of time spent reading it. The outcome can be thought of as
user satisfaction.
MIMIC III: The Medical Information Mart for Intensive Care (MIMIC III) (Johnson et al., 2016)
database consists of observational data from patients in the ICU. We extracted 3000 patients that receive
antibiotics treatment and we used as features 9 clinical covariates measured during the day of ICU admission.
Again, the features were scaled in the [0, 1] interval. In this setting, we can considered as treatments the
different antibiotics and their corresponding dosages.
For a summary description of the datasets, see table 6. The datasets are split into 64/16/20% for training,
validation and testing respectively. The validation dataset is used for hyperparameter optimization.
TCGA News MIMIC
Number of samples 9659 10000 3000
Number of features 4000 2858 9
Number of treatments 3* 3 2
Table 6: Summary description of datasets. *: for our final experiment in Appendix 7.6 we increase the number of
treatments in TCGA to 6 and 9.
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Appendix F. Benchmarks
We use the publicly available GitHub implementation of DRNet provided by Schwab et al. (2019): https:
//github.com/d909b/drnet. Moreover, we also used a GPS implementation similar to the one from
https://github.com/d909b/drnet which uses the causaldrf R package (Galagate, 2016).
More spcifically, the GPS implementation uses a normal treatment model, a linear treatment formula and a
2-nd degree polynomial for the outcome. Moreover, for the TCGA and News datasets, we performed PCA
and only used the 50 principal components as input to the GPS model to reduce computational complexity.
Hyperparameter optimization: The validation split of the dataset is used for hyperparameter opti-
mization. For the DRNet benchmarks we use the same hyperparameter optimization proposed by Schwab
et al. (2019) with the hyperparameter search ranges described in Table 7. For SCIGAN, we use the hyperpa-
rameter optimization method proposed in GANITE (Yoon et al., 2018), where we use the complete dataset
from the counterfactual generator to evaluate the MISE on the inference network. We perform a random
search (Bergstra and Bengio, 2012) for hyperparameter optimization over the search ranges in Table 8. For
a fair comparison, for the MLP-M model we used the same architecture used in the inference network of
SCIGAN. Similarly, for the MLP model we use the same architecture as for the MLP-M, but without the
multitask heads.
Hyperparameter Search range
Batch size 32, 64, 128
Number of units per hidden layer 24, 48, 96, 192
Number of hidden layers 2, 3
Dropout percentage 0.0, 0.2
Imbalance penalty weight∗ 0.1, 1.0, 10.0
Fixed
Number of dosage strata E 5
Table 7: Hyperparameters search range for DRNet. *: For the DRNet model using Wasserstein regularization only.
Hyperparameter Search range
Batch size 64, 128, 256
Number of units per hidden layer 32, 64, 128
Size of invariant and equivariant representations 16, 32, 64, 128
Fixed
Number of hidden layers per multitask head 2
Number of dosage samples 5
λ 1
Optimization Adam Moment Optimization
Table 8: Hyperparameters search range for SCIGAN.
The hyperparameters used to generate the results for SCIGAN are given in Table 9.
The experiments were run on a system with 6CPUs, an Nvidia K80 Tesla GPU and 56GB of RAM.
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Hyperparameter TCGA News MIMIC
Batch size 128 256 128
Number of units per hidden layer 64 128 32
Size of invariant and equivariant representations 16 32 16
Number of hidden layers per multitask head 2 2 2
Number of dosage samples 5 5 5
λ 1 1 1
Table 9: Hyperparameters used for obtaining results.
Appendix G. Investigating hyperparameter sensitivity (nw)
The performance of the single discriminator causes significant performance drops around nw = 9 across all
metrics. As previously noted, this is due to the dimension of the output space (which for nw = 9 is 27)
being too large. Conversely, we see that our hierarchical discriminator shows much more stable performance
even when nw = 19.
Here we present additional results for our investigation of the hyperparameters nw. Fig. 7 reports
each of the 3 performance metrics as we increase the number of dosage samples, nw, used to train the
discriminators on the News dataset. As with the TCGA results in the main paper we see that the single
discriminator suffers a significant performance decrease when nw is set too high.
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Figure 7: Performance of single vs. hierarchical discriminator when increasing the number of dosage samples (nw)
on News dataset.
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Figure 8: Performance of single vs. hierarchical discriminator when increasing the number of dosage samples (nw)
on TCGA dataset.
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